Comparison
Why is Surgery Partners, Inc. ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 12.45% and Operating profit at 22.01%
2
The company has declared Negative results for the last 3 consecutive quarters
- NET PROFIT(9M) At USD -13.29 MM has Grown at -74.91%
- DEBT-EQUITY RATIO (HY) Highest at 212.07 %
- INTEREST(Q) Highest at USD 73.3 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -50.80%, its profits have fallen by -45.3%
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -1.99% over the previous quarter and currently hold 38.7% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -50.80% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Surgery Partners, Inc. should be less than 10%
- Overall Portfolio exposure to Hospital should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Surgery Partners, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Surgery Partners, Inc.
-50.59%
-1.13
47.31%
S&P 500
13.68%
0.71
19.28%
Quality key factors
Factor
Value
Sales Growth (5y)
12.45%
EBIT Growth (5y)
22.01%
EBIT to Interest (avg)
1.54
Debt to EBITDA (avg)
4.65
Net Debt to Equity (avg)
1.43
Sales to Capital Employed (avg)
0.68
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
9.28%
ROE (avg)
6.38%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.93
EV to EBIT
8.17
EV to EBITDA
6.30
EV to Capital Employed
0.97
EV to Sales
1.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.87%
ROE (Latest)
6.18%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Movement
11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 282.3 MM
NET PROFIT(HY)
Higher at USD 8.51 MM
RAW MATERIAL COST(Y)
Fallen by -15.79% (YoY
-7What is not working for the Company
NET PROFIT(9M)
At USD -13.29 MM has Grown at -74.91%
DEBT-EQUITY RATIO
(HY)
Highest at 212.07 %
INTEREST(Q)
Highest at USD 73.3 MM
Here's what is working for Surgery Partners, Inc.
Net Profit
At USD 8.51 MM has Grown at 201.18%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 282.3 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD 8.51 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Raw Material Cost
Fallen by -15.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Surgery Partners, Inc.
Debt-Equity Ratio
Highest at 212.07 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Interest
Highest at USD 73.3 MM
in the last five periods and Increased by 10.06% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)






